TrialThe oncologist2010

Quality of life in hormone receptor-positive HER-2+ metastatic breast cancer patients during treatment with letrozole alone or in combination with lapatinib.

Beth Sherrill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.